Chemists have developed a revolutionary new way to manufacture natural chemicals by clipping smaller molecules together like Lego. They have used the new method to assemble a scarce anti-inflammatory drug with potential to treat cancer and malaria, pseudopterosin.
“We took small molecules and clipped them together like Lego,” said lead researcher Professor Michael Sherburn, from the Research School of Chemistry.
“The building blocks are carefully designed in such a way that the first reaction generates a product perfectly primed for the second. It’s quite magical. This means you can efficiently build large and complex molecules.”
Medicines of this type have traditionally been made in a cumbersome way. Chemists take a related molecule and renovate it. This is a lengthy process, with unwanted structural features being ripped out and replaced.
“This leads to a lot of waste,” Professor Sherburn said.
The group trialed their innovative new method by making pseudopterosin, a powerful anti-inflammatory and analgesic drug, which is currently only available in tiny quantities extracted from fan coral found in the Bahamas.
The work began as blue-sky research, with the researchers trying to work out a way to make supposedly impossible molecules of cross-conjugated hydrocarbons.
Before trying the experiments the team ran simulations on the Raijin supercomputer, which indicated that their method had potential.
“Ours is an empowering and enabling technique, allowing a smarter and faster way to make important substances,” said Dr Chris Newton, who did the research in the laboratory as a PhD student.
The Latest on: Manufacturing new drugs
via Google News
The Latest on: Manufacturing new drugs
- New technology enables fast protein synthesison May 28, 2020 at 11:02 am
Many proteins are useful as drugs for disorders such as diabetes, cancer, and arthritis. Synthesizing artificial versions of these proteins is a time-consuming process that requires genetically ...
- Trump administration signs up new company to make COVID-19 drugs in U.S.on May 28, 2020 at 10:32 am
The administration has been looking to build up the ability to produce drugs and their raw materials in the United States after the global pandemic exposed the industry's dependence on China and India ...
- Denali unveils new way of crossing blood brain barrier as the big neuroscience bet enters its clinical yearson May 28, 2020 at 10:28 am
Five years ago, as much of pharma began leaving neuroscience, three big-name scientists from Genentech and some A-list investors, including ARCH and Flagship, made a $217 million bet that new genetic ...
- Moscow Raises Death Toll; Gilead, Roche Pair Drugs: Virus Updateon May 28, 2020 at 8:15 am
South Korea reported its biggest spike in new coronavirus cases in almost two months, raising concern about a second wave of infections. Small clusters also emerged in several locations in Japan in ...
- Alzheimer's Drugs Market 2030: Rise in Research and Developmental Activities to Boost the Marketon May 28, 2020 at 8:10 am
MIR has published a new report titled Global Alzheimers Drugs Market Global Industry Analysis Size Share Growth Trends and Forecast 2019 2030 According to the report the global Alzheimers Drugs market ...
- Anti-Obesity Prescription Drugs Market Shows Strong Growth Forecast 2017 - 2026on May 28, 2020 at 7:57 am
The global anti obesity prescription drugs market is expected to see promising growth in forthcoming year as reported by TMR Because of the lower rate of achievement and removal of centralized drugs ...
- EU plans permanent stockpile of essential drugs, medical gearon May 28, 2020 at 5:55 am
The European Commission said on Thursday it wanted to set up a permanent reserve of essential drugs and medical equipment to address shortages that have dogged the EU for years and worsened throughout ...
- PHAS To Begin COVID-19 Drug Trial In June, MRSN Hits New High, LJPC Plunges, RCUS On Watchon May 27, 2020 at 10:41 pm
Today's Daily Dose brings you news about NantKwest teaming up with ImmunityBio to accelerate the development of vaccines and therapeutics for COVID-19; Mersana's promising data in ovarian cancer and ...
- Trump Wants To Bring Drug Manufacturing Back To United States. Pharma, Not So Much.on May 26, 2020 at 9:48 pm
Read about the biggest pharmaceutical development and pricing stories from the past week in KHN’s Prescription Drug Watch roundup.
- Trump Signs Deal With Company in Effort Shift Drug Manufacturing to U.S.: New York Timeson May 20, 2020 at 8:23 am
U.S. President Donald Trump's administration awarded a contract worth up to $812 million for a new U.S. company to manufacture drugs and drug ingredients to fight COVID-19 on American soil, aiming to ...
via Bing News